Tenders of Ministry Of Social Affairs And Health

The Purpose Of Stm And The Customer Is To Procure Pneumococcal Vaccines For Risk Groups Required For The National Vaccination Programme In Finland. The Tendered Vaccine Must Be Suitable For Patients 74-year-old And Under According To Vaccine's Summary Of Product Characteristics (spc). Target Group For Risk Group Vaccinations Is Patients Under 75-year-old With Severe Chronic Disease (for Example Kidney Disease Or Severe Lung Disease). Finnish Institute For Health And Welfare Reserves The Right To Change And Update The Definition Of Risk Groups When Needed. More Information About National Vaccination Programme And Vaccinations Can Be Found On The Website Of The Finnish Institute For Health And Welfare: Https://thl.fi/fi/web/infektiotaudit-ja-rokotukset/rokotteet-a-o/pneumokokkirokotteet The Customer Will Implement The Procurement On Behalf Of Stm. The Roles Of Stm And Customer Are Described In More Detail In Section "presentation Of The Contracting Authority". The Subject Of Procurement And The Mandatory Requirements Relating To It Are Described In Detail In This Call For Tender And Its Annexes. The Contract Will Be Awarded To One Supplier Based On A Comparison Of Tenders. Contract Period The Contract´s Duration Is About One Year 2024. Estimated Quantity For The Contract Period Depends On The Tendered Price Since The Total Price For Procurement Is Fixed And The Total Cost For This Procurement Is 650,000.00 Euros (excluding Vat) For The Contract Period. The Contract Period Shall Enter Into Force Once The Contract Has Been Signed, And Expire When All Contractual Duties Have Been Performed. After The Contract Period, The Customer Reserves The Right For The Option Described In Section "description Of Renewals". Tenders Will Be Compared In The Manner Described In Section "grounds For Decision" Of The Call For Tender.. The Procurement Is Related To A Project And/or Programme Financed By European Union Funds: No

Finland – Vaccines – Enhanced Seasonal Influenza Vaccine 2024-2025 (2025-2026, 2026-2027)

Live Attenuated Influenza Vaccine (laiv) 2023-2024 And Options (2024-2025, 2025-2026, 2026-2027)

The Purpose Of Stm And The Customer Is To Procure Quadrivalent Influenza Vaccine Required And Suitable For The National Vaccination Programme In Finland. The Tendered Vaccine Must Be Suitable For Adults And Children From Six (6) Months Of Age And Older For The Prevention Of Influenza Disease. More Information About National Vaccination Programme And Vaccinations Can Be Found On The Website Of The Finnish Institute For Health And Welfare: Https://thl.fi/en/web/infectious-diseases-and-vaccinations/vaccines-a-to-z/influenza-vaccine The Customer Will Implement The Procurement On Behalf Of Stm. The Roles Of Stm And Customer Are Described In More Detail In Section "presentation Of The Contracting Authority". The Subject Of Procurement And The Mandatory Requirements Relating To It Are Described In Detail In This Call For Tender And Its Annexes. The Contract Will Be Awarded To One Supplier Based On A Comparison Of Tenders. Contract Period Estimated Quantity For The Contract Period Is 1.700.000 Doses For The Influenza Season 2023-2024. The Customer Reserves The Right To Increase Or Decrease The Ordered Numbers Of Doses By Up To 20%. The Contract Period Shall Enter Into Force Once The Contract Has Been Signed, And Expire When All Contractual Duties Have Been Performed. After The Contract Period, The Customer Reserves The Right For The Option Described In Section "description Of Renewals". Tenders Will Be Compared In The Manner Described In Section "grounds For Decision" Of The Call For Tender.. The Procurement Is Related To A Project And/or Programme Financed By European Union Funds: No

Pneumococcal Vaccine For Risk Groups 2024 (2025, 2026 And 2027)